Optimi Health

Optimi Health is pleased to announce that it has entered into an exploratory supply agreement with ATMA Journey Centers, a privately held facilitator of psilocybin-assisted therapy and practitioner training services for palliative care and mental health conditions based in Calgary, Alberta.

The Company has finalized an agreement which will supply psilocybin products to ATMA for future therapist initiatives and supply requirements.

“Few organizations have made as significant a contribution in recent years to the evolving regulatory conversation around psilocybin-assisted therapy as ATMA Journey Centers,” said Bill Ciprick, CEO of Optimi Health. “Optimi is deeply gratified to be able to provide them with this test supply of natural psilocybin in order to facilitate research that may lead to better mental health services for healthcare workers while testing the potential to expand the scale of available psilocybin therapies.”

Full press release here: http://ow.ly/tovc50JsGGP

Optimi Health is pleased to announce an historic milestone on the Company’s road to commercialization with the successful completion of its first batches of psilocybin and functional mushrooms.

Read the full press release: http://ow.ly/wuky50JhXrG

The Optimi leadership team is looking forward to taking part in this year's Catalyst Presents. Join us to help guide Canada's psychedelic journey.

This 3rd annual Catalyst Summit will take place at Queen's University in Kingston, Ontario from May 20-22.

Optimi CEO Bill Ciprick will speak at the Building Canada's Psychedelic Supply panel, from 2:30pm - 3:30pm EST on Saturday, May 21.

Optimi Founder & Director Dane Stevens will speak at the Raising Capital & Understanding the Investor From Within panel from 1:15pm - 2:30pm EST on Friday, May 20, AND the Business of Psychedelics: What Happens After Regulation panel from 3:30 pm - 4:30 pm EST on Saturday, May 21.

Finally, Optimi Chief Science Officer Justin Kirkland will speak at the Landmark Trials Looking Forward panel from 9:00 am - 10:00 am EST on Saturday, May 21.

Complete conference details and tickets are available here: http://ow.ly/QE1V50J4btz

Picked up by the Financial Post.

"Optimi Health Corp. is pleased to announce that it will be inaugurating its recently completed psilocybin cultivation facility with a grand opening event and reception for members of the media, investors and other stakeholders relevant to the Company’s developing position as a leading supplier in the field of psychedelic and functional mushrooms on Friday, May 27th, 2022."

Full release here:

Optimi Health Opens Canada's Largest GMP-Grade Licensed Psilocybin Cultivation Facility Company will host in-person and virtual tours for media, investors, and residents on May 27, 2022.